# Genevide

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/genevide

- Industry: Medical Devices & Equipment
- Headquarters: Suzhou, China
- Website: www.genevide.com
- Total disclosed funding: $7.8M
- Latest round: Angel (Sep 9, 2021)
- Investors on record: 2

## About

Founded in 2019 and based in Jiangsu, China, Genevide is a biotech company that focused on gene research and development.  The company received GMP certification in December 2021 for the first veterinary diagnostic product line in Jiangsu Province. The company's founding and core team members graduated from Tsinghua University, Chinese Academy of Sciences, NUS, PSU, UCLA and other renowned universities in China and abroad. It has constructed a R&D center of more than 4,000 square meters, an enzyme raw material production center and a GMP production center for IVD class III medical devices. In September 2021, Genevide raised CNY 50 million in angel funding led by new investor Bio Venture, with participation from another new investor Qiming Venture Partners.

The company is engaged in the production and sale of medical devices, the development of industrial enzyme preparations, and the development of fermentation process optimization technology. It has developed its own Enzymes-mediated Duplex Exponential Amplification (EmDEA™) nPOCT technology platform.

The company will use the angel funding for the rapid advancement of core product development and registration of nPOCT for multiple pathogens, and further upgrading the innovative molecular enzyme cycle screening technology platform based on enzyme characterization methods.

## Funding rounds

- Angel, Sep 9, 2021, $7.8M — Qiming Venture Partners, YuanBio Venture

## Investors

- Qiming Venture Partners (https://capitalatlas.ai/funds/qiming-venture-partners) — Angel
- YuanBio Venture (https://capitalatlas.ai/funds/yuanbio-venture) — Angel